{"rows":[{"id":2630,"title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV).","authors":"Studerus E, Gamma A, Vollenweider FX","journal":"PloS one","publication_date":"2010-08-31","publication_year":2010,"doi":"10.1371/journal.pone.0012412","pubmed_id":"20824211","openalex_id":"https://openalex.org/W2075969679","source_url":"https://pubmed.ncbi.nlm.nih.gov/20824211/","substance_tags":"psilocybin","topic_tags":"Consciousness","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:20824211","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/20824211/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:20824211","source_url":"https://pubmed.ncbi.nlm.nih.gov/20824211/","doi":"10.1371/journal.pone.0012412","pmid":"20824211","publication_date":"2010-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":2610,"title":"Prediction of psilocybin response in healthy volunteers.","authors":"Studerus E, Gamma A, Kometer M, Vollenweider FX","journal":"PloS one","publication_date":"2012-01-01","publication_year":2012,"doi":"10.1371/journal.pone.0030800","pubmed_id":"22363492","openalex_id":"https://openalex.org/W2003424951","source_url":"https://pubmed.ncbi.nlm.nih.gov/22363492/","substance_tags":"psilocybin","topic_tags":"Anxiety,Personality Change,Emotional Processing,Mystical Experience,Healthy Volunteers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:22363492","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/22363492/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:22363492","source_url":"https://pubmed.ncbi.nlm.nih.gov/22363492/","doi":"10.1371/journal.pone.0030800","pmid":"22363492","publication_date":"2012-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2585,"title":"Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.","authors":"Kosentka P, Sprague SL, Ryberg M, Gartz J, May AL, Campagna SR, Matheny PB","journal":"PloS one","publication_date":"2013-01-01","publication_year":2013,"doi":"10.1371/journal.pone.0064646","pubmed_id":"23717644","openalex_id":"https://openalex.org/W2039278365","source_url":"https://pubmed.ncbi.nlm.nih.gov/23717644/","substance_tags":"psilocybin","topic_tags":"Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:23717644","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/23717644/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:23717644","source_url":"https://pubmed.ncbi.nlm.nih.gov/23717644/","doi":"10.1371/journal.pone.0064646","pmid":"23717644","publication_date":"2013-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2579,"title":"Psychedelics and mental health: a population study.","authors":"Krebs TS, Johansen PØ","journal":"PloS one","publication_date":"2013-01-01","publication_year":2013,"doi":"10.1371/journal.pone.0063972","pubmed_id":"23976938","openalex_id":"https://openalex.org/W2014761647","source_url":"https://pubmed.ncbi.nlm.nih.gov/23976938/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:23976938","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/23976938/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:23976938","source_url":"https://pubmed.ncbi.nlm.nih.gov/23976938/","doi":"10.1371/journal.pone.0063972","pmid":"23976938","publication_date":"2013-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2546,"title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.","authors":"Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB","journal":"PloS one","publication_date":"2015-01-01","publication_year":2015,"doi":"10.1371/journal.pone.0118143","pubmed_id":"25693169","openalex_id":"https://openalex.org/W2093477837","source_url":"https://pubmed.ncbi.nlm.nih.gov/25693169/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Default Mode Network,Consciousness","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:25693169","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/25693169/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:25693169","source_url":"https://pubmed.ncbi.nlm.nih.gov/25693169/","doi":"10.1371/journal.pone.0118143","pmid":"25693169","publication_date":"2015-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2349,"title":"Survey of subjective \"God encounter experiences\": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.","authors":"Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R","journal":"PloS one","publication_date":"2019-01-01","publication_year":2019,"doi":"10.1371/journal.pone.0214377","pubmed_id":"31013281","openalex_id":"https://openalex.org/W2940999002","source_url":"https://pubmed.ncbi.nlm.nih.gov/31013281/","substance_tags":"psilocybin","topic_tags":"Spirituality,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:31013281","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31013281/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31013281","source_url":"https://pubmed.ncbi.nlm.nih.gov/31013281/","doi":"10.1371/journal.pone.0214377","pmid":"31013281","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2295,"title":"Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.","authors":"Bienemann B, Ruschel NS, Campos ML, Negreiros MA, Mograbi DC","journal":"PloS one","publication_date":"2020-01-01","publication_year":2020,"doi":"10.1371/journal.pone.0229067","pubmed_id":"32084160","openalex_id":"https://openalex.org/W3007379062","source_url":"https://pubmed.ncbi.nlm.nih.gov/32084160/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Treatment-Resistant Depression,Safety,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32084160","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32084160/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32084160","source_url":"https://pubmed.ncbi.nlm.nih.gov/32084160/","doi":"10.1371/journal.pone.0229067","pmid":"32084160","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1806,"title":"Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).","authors":"Dworatzyk K, Jansen T, Schmidt TT","journal":"PloS one","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1371/journal.pone.0264927","pubmed_id":"35294453","openalex_id":"https://openalex.org/W4220968891","source_url":"https://pubmed.ncbi.nlm.nih.gov/35294453/","substance_tags":"psilocybin","topic_tags":"Anxiety,Consciousness,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35294453","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35294453/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35294453","source_url":"https://pubmed.ncbi.nlm.nih.gov/35294453/","doi":"10.1371/journal.pone.0264927","pmid":"35294453","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1710,"title":"Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.","authors":"Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR","journal":"PloS one","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1371/journal.pone.0271926","pubmed_id":"36001643","openalex_id":"https://openalex.org/W4293101934","source_url":"https://pubmed.ncbi.nlm.nih.gov/36001643/","substance_tags":"psilocybin","topic_tags":"Spirituality,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:36001643","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36001643/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36001643","source_url":"https://pubmed.ncbi.nlm.nih.gov/36001643/","doi":"10.1371/journal.pone.0271926","pmid":"36001643","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1620,"title":"\"A sense of the bigger picture:\" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.","authors":"DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J, Michalak E","journal":"PloS one","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1371/journal.pone.0279073","pubmed_id":"36516137","openalex_id":"https://openalex.org/W4311439362","source_url":"https://pubmed.ncbi.nlm.nih.gov/36516137/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36516137","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36516137/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36516137","source_url":"https://pubmed.ncbi.nlm.nih.gov/36516137/","doi":"10.1371/journal.pone.0279073","pmid":"36516137","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1199,"title":"The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.","authors":"Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK","journal":"PloS one","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1371/journal.pone.0300501","pubmed_id":"38483940","openalex_id":"https://openalex.org/W4392797453","source_url":"https://pubmed.ncbi.nlm.nih.gov/38483940/","substance_tags":"psilocybin","topic_tags":"Depression,Mystical Experience,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:38483940","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38483940/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38483940","source_url":"https://pubmed.ncbi.nlm.nih.gov/38483940/","doi":"10.1371/journal.pone.0300501","pmid":"38483940","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":988,"title":"Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.","authors":"Kim K, Yusuf A, Sud A, Persaud N, Kirubarajan A, Moller M, Lloyd T, O'Neill B","journal":"PloS one","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1371/journal.pone.0309911","pubmed_id":"39446753","openalex_id":"https://openalex.org/W4403721028","source_url":"https://pubmed.ncbi.nlm.nih.gov/39446753/","substance_tags":"psilocybin","topic_tags":"Depression,Healthcare Workers,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39446753","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39446753/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39446753","source_url":"https://pubmed.ncbi.nlm.nih.gov/39446753/","doi":"10.1371/journal.pone.0309911","pmid":"39446753","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":855,"title":"Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.","authors":"Meshkat S, J Zeifman R, Stewart K, Janssen-Aguilar R, Lou W, Jetly R, Monson CM, Bhat V","journal":"PloS one","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1371/journal.pone.0313741","pubmed_id":"39823496","openalex_id":"https://openalex.org/W4406512218","source_url":"https://pubmed.ncbi.nlm.nih.gov/39823496/","substance_tags":"psilocybin","topic_tags":"PTSD,Mechanism of Action,Wellbeing,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39823496","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39823496/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39823496","source_url":"https://pubmed.ncbi.nlm.nih.gov/39823496/","doi":"10.1371/journal.pone.0313741","pmid":"39823496","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":704,"title":"A landscape analysis of psychedelic retreat organizations advertising online.","authors":"Neitzke-Spruill L, Beit CS, Robinson JO, Singh N, Kambala S, Ramesh R, McGuire AL","journal":"PloS one","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1371/journal.pone.0321648","pubmed_id":"40315211","openalex_id":"https://openalex.org/W4410030136","source_url":"https://pubmed.ncbi.nlm.nih.gov/40315211/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Wellbeing,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40315211","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40315211/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40315211","source_url":"https://pubmed.ncbi.nlm.nih.gov/40315211/","doi":"10.1371/journal.pone.0321648","pmid":"40315211","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":703,"title":"A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.","authors":"Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B","journal":"PloS one","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1371/journal.pone.0318343","pubmed_id":"40327705","openalex_id":"https://openalex.org/W4410112263","source_url":"https://pubmed.ncbi.nlm.nih.gov/40327705/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40327705","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40327705/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40327705","source_url":"https://pubmed.ncbi.nlm.nih.gov/40327705/","doi":"10.1371/journal.pone.0318343","pmid":"40327705","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":701,"title":"Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder.","authors":"Jones G","journal":"PloS one","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1371/journal.pone.0321461","pubmed_id":"40334252","openalex_id":"https://openalex.org/W4410148514","source_url":"https://pubmed.ncbi.nlm.nih.gov/40334252/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40334252","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40334252/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40334252","source_url":"https://pubmed.ncbi.nlm.nih.gov/40334252/","doi":"10.1371/journal.pone.0321461","pmid":"40334252","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":239,"title":"5 Years of bipolar disorder conversations on Reddit: Methods, key topics and future directions.","authors":"Poh C, Head C, Nunez JJ, Lapadat L, Morton E, Collaborative RESearch Team to Study Psychosocial Issues in Bipolar Disorder (CREST.BD), Michalak EE","journal":"PloS one","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1371/journal.pone.0338622","pubmed_id":"41790781","openalex_id":"https://openalex.org/W7134138263","source_url":"https://pubmed.ncbi.nlm.nih.gov/41790781/","substance_tags":"psilocybin","topic_tags":"Healthcare Workers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:51","bibtex":null,"source_record_id":"PMID:41790781","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41790781/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41790781","source_url":"https://pubmed.ncbi.nlm.nih.gov/41790781/","doi":"10.1371/journal.pone.0338622","pmid":"41790781","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":17,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"PloS one","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}